HealthEquity, Inc. $HQY Shares Sold by Farallon Capital Management LLC

Farallon Capital Management LLC lowered its position in HealthEquity, Inc. (NASDAQ:HQY) by 98.4% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,000 shares of the company’s stock after selling 314,800 shares during the quarter. Farallon Capital Management LLC’s holdings in HealthEquity were worth $474,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. True Wealth Design LLC grew its stake in HealthEquity by 3,522.2% in the 3rd quarter. True Wealth Design LLC now owns 326 shares of the company’s stock valued at $31,000 after acquiring an additional 317 shares during the last quarter. Farther Finance Advisors LLC raised its position in HealthEquity by 59.3% during the third quarter. Farther Finance Advisors LLC now owns 392 shares of the company’s stock worth $37,000 after acquiring an additional 146 shares during the last quarter. AlphaQuest LLC raised its position in HealthEquity by 52.2% during the third quarter. AlphaQuest LLC now owns 624 shares of the company’s stock worth $59,000 after acquiring an additional 214 shares during the last quarter. Allworth Financial LP lifted its holdings in shares of HealthEquity by 283.1% in the second quarter. Allworth Financial LP now owns 747 shares of the company’s stock valued at $78,000 after purchasing an additional 552 shares in the last quarter. Finally, SBI Securities Co. Ltd. lifted its holdings in shares of HealthEquity by 25,100.0% in the second quarter. SBI Securities Co. Ltd. now owns 756 shares of the company’s stock valued at $79,000 after purchasing an additional 753 shares in the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

HealthEquity Stock Performance

NASDAQ:HQY opened at $77.81 on Monday. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The firm has a market cap of $6.65 billion, a PE ratio of 35.69, a P/E/G ratio of 0.97 and a beta of 0.26. The firm has a 50 day simple moving average of $81.91 and a 200-day simple moving average of $90.41. HealthEquity, Inc. has a 1-year low of $72.76 and a 1-year high of $116.65.

Insider Activity at HealthEquity

In other HealthEquity news, EVP Elimelech Rosner sold 10,959 shares of the business’s stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the transaction, the executive vice president directly owned 45,742 shares in the company, valued at approximately $4,366,073.90. The trade was a 19.33% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Delano Ladd sold 1,500 shares of the stock in a transaction on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the transaction, the executive vice president directly owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their position. The SEC filing for this sale provides additional information. 1.50% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on the stock. Jefferies Financial Group set a $108.00 price objective on shares of HealthEquity in a research note on Thursday, February 19th. Barclays reduced their target price on HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 18th. Wall Street Zen upgraded HealthEquity from a “hold” rating to a “buy” rating in a report on Monday, January 19th. Citigroup reissued an “outperform” rating on shares of HealthEquity in a research report on Thursday, December 4th. Finally, Raymond James Financial set a $100.00 price target on HealthEquity in a report on Tuesday, February 17th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $112.00.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.